1 |
Yang X, Lin C, Liu J, Zhang Y, Deng T, Wei M, Pan S, Lu L, Li X, Tian G, Mi J, Xu F, Yang C. Identification of the regulatory mechanism of ACE2 in COVID-19-induced kidney damage with systems genetics approach. J Mol Med (Berl) 2023. [PMID: 36951969 DOI: 10.1007/s00109-023-02304-9] [Reference Citation Analysis]
|
2 |
Somaili M. Coronavirus 19 (COVID-19) and Syndrome of Inappropriate Anti-Diuretic Hormone Secretion (SIADH): A Review of Literature. Post COVID-19 - Effects on Human Health [Working Title] 2023. [DOI: 10.5772/intechopen.110717] [Reference Citation Analysis]
|
3 |
Mcdonnell T, Wu HHL, Kalra PA, Chinnadurai R. COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review. Biomedicines 2023;11:926. [DOI: 10.3390/biomedicines11030926] [Reference Citation Analysis]
|
4 |
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, Soliman Mohammadi-Samani. Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2. Int Immunopharmacol 2023:109968. [ DOI: 10.1016/j.intimp.2023.109968] [Reference Citation Analysis]
|
5 |
Malek H, Hedayati R, Yasemi M. The Usefulness of 99m Tc Diethylenetriamine Pentaacetate (DTPA) or Mercaptoacetyltriglycine (MAG3) Renal Perfusion Scan in Assessing Chronic Renal Complications of COVID-19. J Health Rep Technol 2023;9. [DOI: 10.5812/jhrt-122894] [Reference Citation Analysis]
|
6 |
Mallhi TH, Khan YH, Alzarea AI, Khan FU, Alotaibi NH, Alanazi AS, Butt MH, Alatawi AD, Salman M, Alzarea SI, Almalki ZS, Alghazi MA, Algarni MA. Incidence, risk factors and outcomes of acute kidney injury among COVID-19 patients: A systematic review of systematic reviews. Front Med 2022;9. [DOI: 10.3389/fmed.2022.973030] [Reference Citation Analysis]
|
7 |
Pelle MC, Zaffina I, Lucà S, Forte V, Trapanese V, Melina M, Giofrè F, Arturi F. Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options. Life (Basel) 2022;12:1605. [PMID: 36295042 DOI: 10.3390/life12101605] [Reference Citation Analysis]
|
8 |
Vanslambrouck JM, Wilson SB, Tan KS, Groenewegen E, Rudraraju R, Neil J, Lawlor KT, Mah S, Scurr M, Howden SE, Subbarao K, Little MH. Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids. Nat Commun 2022;13:5943. [PMID: 36209212 DOI: 10.1038/s41467-022-33623-z] [Reference Citation Analysis]
|
9 |
Amin A, Moon R, Agiro A, Rosenthal N, Brown H, Legg R, Pottorf W. In-hospital mortality, length of stay, and hospitalization cost of COVID-19 patients with and without hyperkalemia. Am J Med Sci 2022;364:444-53. [PMID: 35490703 DOI: 10.1016/j.amjms.2022.04.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
10 |
Alenazy MF, Aljohar HI, Alruwaili AR, Daghestani MH, Alonazi MA, Labban RS, El-ansary AK, Balto HA. Gut Microbiota Dynamics in Relation to Long-COVID-19 Syndrome: Role of Probiotics to Combat Psychiatric Complications. Metabolites 2022;12:912. [DOI: 10.3390/metabo12100912] [Reference Citation Analysis]
|
11 |
Nogueira GM, Silva NLOR, Moura AF, Duarte Silveira MA, Moura-Neto JA. Acute kidney injury and electrolyte disorders in COVID-19. World J Virol 2022; 11(5): 283-292 [DOI: 10.5501/wjv.v11.i5.283] [Reference Citation Analysis]
|
12 |
Figueiredo FA, Ramos LEF, Silva RT, Ponce D, de Carvalho RLR, Schwarzbold AV, Maurílio AO, Scotton ALBA, Garbini AF, Farace BL, Garcia BM, da Silva CTCA, Cimini CCR, de Carvalho CA, Dias CDS, Silveira DV, Manenti ERF, Cenci EPA, Anschau F, Aranha FG, de Aguiar FC, Bartolazzi F, Vietta GG, Nascimento GF, Noal HC, Duani H, Vianna HR, Guimarães HC, de Alvarenga JC, Chatkin JM, de Morais JDP, Machado-Rugolo J, Ruschel KB, Martins KPMP, Menezes LSM, Couto LSF, de Castro LC, Nasi LA, Cabral MAS, Floriani MA, Souza MD, Souza-Silva MVR, Carneiro M, de Godoy MF, Bicalho MAC, Lima MCPB, Aliberti MJR, Nogueira MCA, Martins MFL, Guimarães-Júnior MH, Sampaio NDCS, de Oliveira NR, Ziegelmann PK, Andrade PGS, Assaf PL, Martelli PJL, Delfino-Pereira P, Martins RC, Menezes RM, Francisco SC, Araújo SF, Oliveira TF, de Oliveira TC, Sales TLS, Avelino-Silva TJ, Ramires YC, Pires MC, Marcolino MS. Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients. BMC Med 2022;20:324. [PMID: 36056335 DOI: 10.1186/s12916-022-02503-0] [Reference Citation Analysis]
|
13 |
Naghmeh Moslehi, Mahsa Hadipour Jahromy, Pegah Ashrafi, Kimia Vatani, Mohammad A. H. Nemati, Parnian A. Moghadam, Fatemeh Rostamian, Mana H. Jahromi. Multi-organ system involvement in coronavirus disease 2019 (COVID-19): A mega review. J Family Med Prim Care 2022;11. [PMID: 36505634 DOI: 10.4103/jfmpc.jfmpc_1570_21] [Reference Citation Analysis]
|
14 |
Jalali KS, Basala A, Habeb M. Arterio-Venous Thrombosis and Spontaneous Bleeding in COVID-19-Associated Coagulopathy: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.27770] [Reference Citation Analysis]
|
15 |
Amin MN, Bahoosh SR, Eftekhari M, Hosseinzadeh L. Herbal Sources of Magnesium as a Promising Multifaceted Intervention for the Management of COVID-19. Natural Product Communications 2022;17:1934578X2211162. [DOI: 10.1177/1934578x221116235] [Reference Citation Analysis]
|
16 |
Shah MW, Ahmad T, Khan M, Muhammad S, Sun G. Global research on vitamin D and coronavirus disease 2019: A bibliometric and visualized study. Medicine (Baltimore) 2022;101:e29768. [PMID: 35801745 DOI: 10.1097/MD.0000000000029768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
17 |
Liu CW, Jeyakumar N, McArthur E, Sontrop JM, Myran DT, Schwartz KL, Sood MM, Tanuseputro P, Garg AX. SARS-CoV-2 testing, infection and outcomes among Ontario physicians: a descriptive population-based cohort study. CMAJ Open 2022;10:E657-65. [PMID: 35853660 DOI: 10.9778/cmajo.20210263] [Reference Citation Analysis]
|
18 |
Ward B, Yombi JC, Balligand J, Cani PD, Collet J, de Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr dit Ruys S, Vertommen D, Elens L, Belkhir L. HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. Viruses 2022;14:1373. [DOI: 10.3390/v14071373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
19 |
Havasi A, Visan S, Cainap C, Cainap SS, Mihaila AA, Pop L. Influenza A, Influenza B, and SARS-CoV-2 Similarities and Differences – A Focus on Diagnosis. Front Microbiol 2022;13:908525. [DOI: 10.3389/fmicb.2022.908525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
20 |
Puicón-Suárez JB, Zeña-Ñañez S, Failoc-Rojas VE. Association between chronic kidney disease and mortality in patients with a confirmed COVID-19 diagnosis. PeerJ 2022;10:e13437. [PMID: 35722260 DOI: 10.7717/peerj.13437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
21 |
Mufarrih SH, Qureshi NQ, Yunus R, Ngo D, Katz D, Krakower D, Bhambhani V, Quadir J, Solleveld P, Banner-Goodspeed V, Mahmood F, Matyal R. Influence of Increasing Age and Body Mass Index of Gender in COVID-19 Patients. J Womens Health (Larchmt) 2022;31:779-86. [PMID: 35708572 DOI: 10.1089/jwh.2021.0615] [Reference Citation Analysis]
|
22 |
Ngeow WC, Tang L, Ho JY, Tay HW, Wong RCW, Ahmad MS, Marla V, Sekar K. The Provision of Dental Care to Post COVID-19 Survivors. A Concise Review. International Dental Journal 2022. [DOI: 10.1016/j.identj.2022.05.009] [Reference Citation Analysis]
|
23 |
Dyrbuś M, Oraczewska A, Szmigiel S, Gawęda S, Kluszczyk P, Cyzowski T, Jędrzejek M, Dubik P, Kozłowski M, Kwiatek S, Celińska B, Wita M, Trejnowska E, Swinarew A, Darocha T, Barczyk A, Skoczyński S. Mallampati Score Is an Independent Predictor of Active Oxygen Therapy in Patients with COVID-19. J Clin Med 2022;11. [PMID: 35683347 DOI: 10.3390/jcm11112958] [Reference Citation Analysis]
|
24 |
Shukla AK, Misra S. An overview of post COVID sequelae. J Basic Clin Physiol Pharmacol 2022. [PMID: 35428040 DOI: 10.1515/jbcpp-2022-0057] [Reference Citation Analysis]
|
25 |
Cataño-correa JC, Cardona-arias JA, Porras-mancilla JP, Tabares-garcía M. Comparison of Survival and Clinical Profile of Adults with COVID-19 Hospitalized in Two Clinics in Medellín, Colombia. Curr Clin Micro Rpt. [DOI: 10.1007/s40588-022-00179-x] [Reference Citation Analysis]
|
26 |
Nursyifa Fadiyah N, Megawati G, Luftimas DE. Potential of Omega 3 Supplementation for Coronavirus Disease 2019 (COVID-19): A Scoping Review. IJGM 2022;Volume 15:3915-22. [DOI: 10.2147/ijgm.s357460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
27 |
Babajani A, Moeinabadi-Bidgoli K, Niknejad F, Rismanchi H, Shafiee S, Shariatzadeh S, Jamshidi E, Farjoo MH, Niknejad H. Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation. Stem Cell Res Ther 2022;13:126. [PMID: 35337387 DOI: 10.1186/s13287-022-02794-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
28 |
Sifaat M, Patel P, Sheikh R, Ghaffar D, Vaishnav H, Nahar L, Rupani S, Quadri S, Anand V. Cardiorenal Disease in COVID-19 Patients. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-6. [DOI: 10.1155/2022/4640788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
29 |
Liao Z, Zhang Z, Liu Q. Hydroxychloroquine/chloroquine and the risk of acute kidney injury in COVID-19 patients: a systematic review and meta-analysis. Renal Failure 2022;44:415-25. [DOI: 10.1080/0886022x.2022.2046609] [Reference Citation Analysis]
|
30 |
Kirtipal N, Kumar S, Dubey SK, Dwivedi VD, Gireesh Babu K, Malý P, Bharadwaj S. Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect Genet Evol 2022;99:105254. [PMID: 35217145 DOI: 10.1016/j.meegid.2022.105254] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
31 |
Cieślik T, Narloch P, Szurlej A, Kogut K. Indirect Impact of the COVID-19 Pandemic on Natural Gas Consumption by Commercial Consumers in a Selected City in Poland. Energies 2022;15:1393. [DOI: 10.3390/en15041393] [Reference Citation Analysis]
|
32 |
Dugbartey GJ, Alornyo KK, Ohene BO, Boima V, Antwi S, Sener A. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy. Nitric Oxide 2022;120:16-25. [PMID: 35032641 DOI: 10.1016/j.niox.2022.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
|
33 |
Figueiredo FDA, Ramos LEF, Silva RT, Pires MC, Ponce D, de Carvalho RLR, Schwarzbold AV, Maurílio ADO, Alves Scotton ALB, Garbini AF, Farace BL, Garcia BM, da Silva CTCA, Cimini CCR, de Carvalho CA, Dias CDS, Silveira DV, Manenti ERF, de Almeida Cenci EP, Anschau F, Aranha FG, de Aguiar FC, Bartolazzi F, Vietta GG, Nascimento GF, Noal HC, Duani H, Vianna HR, Guimarães HC, de Alvarenga JC, Chatkin JM, de Moraes JPD, Rugolo JM, Ruschel KB, Prado Martins KPM, Menezes LSM, Couto LSF, de Castro LC, Nasi LA, Cabral MADS, Floriani MA, Souza MD, Souza e Silva MVR, Carneiro M, de Godoy MF, Bicalho MAC, Barbosa Lima MCP, Nogueira MCA, Martins MFL, Guimarães-júnior MH, Sampaio NDCS, de Oliveira NR, Ziegelmann PK, Andrade PGS, Assaf PL, de Lima Martelli PJ, Pereira PD, Martins RC, Menezes RM, Francisco SC, Araújo SF, Oliveira TF, de Oliveira TC, Sales TLS, Ramires YC, Marcolino MS. Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patients.. [DOI: 10.1101/2022.01.11.22268631] [Reference Citation Analysis]
|
34 |
Jdiaa SS, Mansour R, El Alayli A, Gautam A, Thomas P, Mustafa RA. COVID-19 and chronic kidney disease: an updated overview of reviews. J Nephrol 2022. [PMID: 35013985 DOI: 10.1007/s40620-021-01206-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
|
35 |
Ke C, Liang J, Liu M, Liu S, Wang C. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019. BMC Nephrol 2022;23:17. [PMID: 34986789 DOI: 10.1186/s12882-021-02597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
36 |
Serwin N, Cecerska-Heryć E, Pius-Sadowska E, Serwin K, Niedźwiedź A, Wiśniewska M, Roszak M, Grygorcewicz B, Skwirczyńska E, Machaliński B, Dołęgowska B. Renal and Inflammation Markers-Renalase, Cystatin C, and NGAL Levels in Asymptomatic and Symptomatic SARS-CoV-2 Infection in a One-Month Follow-Up Study. Diagnostics (Basel) 2022;12:108. [PMID: 35054276 DOI: 10.3390/diagnostics12010108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
37 |
Pramono A, Setiawan YB, Maryani N. Risk Factors for Mortality in Indonesian COVID-19 Patients. Open Access Maced J Med Sci 2022;9:181-184. [DOI: 10.3889/oamjms.2021.7826] [Reference Citation Analysis]
|
38 |
Okada H. COVID-19 and the kidney diseases (Adult). Nihon Shoni Jinzobyo Gakkai Zasshi 2022;35:1-3. [DOI: 10.3165/jjpn.rv.2022.0001] [Reference Citation Analysis]
|
39 |
Zuckier LS. Safe Pulmonary Scintigraphy in the Era of COVID-19. Semin Nucl Med 2022;52:48-55. [PMID: 34330450 DOI: 10.1053/j.semnuclmed.2021.06.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
40 |
Akinci Y. Clinical manifestation and diagnosis. Coronavirus Disease 2022. [DOI: 10.1016/b978-0-12-824409-8.00006-0] [Reference Citation Analysis]
|
41 |
Krishnasamy S, Mantan M, Mishra K, Kapoor K, Brijwal M, Kumar M, Sharma S, Swarnim S, Gaind R, Khandelwal P, Hari P, Sinha A, Bagga A. SARS-CoV-2 infection in children with chronic kidney disease. Pediatr Nephrol 2022;37:849-57. [PMID: 34519896 DOI: 10.1007/s00467-021-05218-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
|
42 |
Meshram H, Banerjee S, Dave R, Chauhan S, Kute V, Patel H, Desai S, Tambi P, Shah N, Shah A. COVID-19 associated acute kidney injury in the second wave of pandemic in India: A single-center retrospective report. Saudi Crit Care J 2022;6:7. [DOI: 10.4103/sccj.sccj_32_21] [Reference Citation Analysis]
|
43 |
Kanavaki AM, Lightfoot CJ, Palmer J, Wilkinson TJ, Smith AC, Jones CR. Kidney Care during COVID-19 in the UK: Perspectives of Healthcare Professionals on Impacts on Care Quality and Staff Well-Being. Int J Environ Res Public Health 2021;19:188. [PMID: 35010447 DOI: 10.3390/ijerph19010188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
44 |
Madanchi N, Stingo FE, Patrick KC, Muthusamy S, Gupta N, Imran Fatani Y, Shah N. Possible Association Between COVID-19 Infection and De Novo Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Cureus 2021. [DOI: 10.7759/cureus.20331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
45 |
Rouamba T, Barry H, Ouédraogo E, Tahita MC, Yaméogo NV, Poda A, Diendéré AE, Ouedraogo AS, Valea I, Koné AM, Thiombiano C, Traoré I, Tarnagda Z, Sawadogo SA, Gansané Z, Kambiré Y, Sanou I, Barro-Traoré F, Drabo MK, Tinto H; CHLORAZ Study Group. Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study. Ther Clin Risk Manag 2021;17:1187-98. [PMID: 34815671 DOI: 10.2147/TCRM.S330813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
46 |
Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
47 |
Ayar Y, Deniz O, Doner B, Kilic I, Demir C, Sahin A. COVID-19 in Elderly Patients with Acute Kidney Injury.. [DOI: 10.1101/2021.11.16.21266324] [Reference Citation Analysis]
|
48 |
Liu K, Yang X, Feng C, Chen M, Zhang C, Wang Y. Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis. J Med Virol 2021. [PMID: 34766661 DOI: 10.1002/jmv.27450] [Reference Citation Analysis]
|
49 |
Vanslambrouck JM, Wilson SB, Tan KS, Groenewegen E, Rudraraju R, Neil J, Lawlor KT, Mah S, Scurr M, Howden SE, Subbarao K, Little MH. Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids.. [DOI: 10.1101/2021.10.14.464320] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
50 |
Nogueira GM, Oliveira MS, Moura AF, Cruz CMS, Moura-Neto JA. COVID-19 in dialysis units: A comprehensive review. World J Virol 2021; 10(5): 264-274 [PMID: 34631476 DOI: 10.5501/wjv.v10.i5.264] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
51 |
Ahmed MH, Hassan A, Molnár J. The Role of Micronutrients to Support Immunity for COVID-19 Prevention. Rev Bras Farmacogn 2021;31:361-74. [PMID: 34493880 DOI: 10.1007/s43450-021-00179-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
52 |
Minh LHN, Abozaid AA, Ha NX, Le Quang L, Gad AG, Tiwari R, Nhat-Le T, Quyen DK, Al-Manaseer B, Kien ND, Vuong NL, Zayan AH, Nhi LHH, Surya Dila KA, Varney J, Tien Huy N. Clinical and laboratory factors associated with coronavirus disease 2019 (Covid-19): A systematic review and meta-analysis. Rev Med Virol 2021;:e2288. [PMID: 34472152 DOI: 10.1002/rmv.2288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
53 |
Kang YW, Lee SC, Jeon SM, Jo E. Roles of Interleukin-17 and Th17 Responses in COVID-19. jbv 2021;51:89-102. [DOI: 10.4167/jbv.2021.51.3.089] [Reference Citation Analysis]
|
54 |
Manickavel S, Sinha N. A pandemic of acute respiratory distress syndrome-role of lung transplant in coronavirus disease-2019-associated respiratory failure. Indian J Thorac Cardiovasc Surg 2021;:1-7. [PMID: 34483505 DOI: 10.1007/s12055-021-01233-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
55 |
Ivannikov AA, Esaulenko AN, Vasilchenko MK, Alidzhanova KG, Petrikov SS. COVID-19 and Cardiovascular System. Part II. Post-COVID Syndrome. Neotložnaâ med pomoŝʹ 2021;10:248-258. [DOI: 10.23934/2223-9022-2021-10-2-248-258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
56 |
Tsukamoto S, Wakui H, Azushima K, Yamaji T, Urate S, Suzuki T, Abe E, Tanaka S, Taguchi S, Yamada T, Kinguchi S, Kamimura D, Yamashita A, Sano D, Nakano M, Hashimoto T, Tamura K. Tissue-specific expression of the SARS-CoV-2 receptor, angiotensin-converting enzyme 2, in mouse models of chronic kidney disease. Sci Rep 2021;11:16843. [PMID: 34413390 DOI: 10.1038/s41598-021-96294-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
57 |
Liakopoulos V, Roumeliotis S, Papachristou S, Papanas N. COVID-19 and the kidney: time to take a closer look. Int Urol Nephrol 2021. [PMID: 34383205 DOI: 10.1007/s11255-021-02976-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
58 |
Butt AA, Yan P, Chotani RA, Shaikh OS. Mortality is not increased in SARS-CoV-2 infected persons with hepatitis C virus infection. Liver Int 2021;41:1824-31. [PMID: 33534931 DOI: 10.1111/liv.14804] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
|
59 |
George JA, Khoza S. SARS-CoV-2 Infection and the Kidneys: An Evolving Picture. Adv Exp Med Biol 2021;1327:107-18. [PMID: 34279832 DOI: 10.1007/978-3-030-71697-4_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
60 |
Carlson N, Nelveg-Kristensen KE, Freese Ballegaard E, Feldt-Rasmussen B, Hornum M, Kamper AL, Gislason G, Torp-Pedersen C. Increased vulnerability to COVID-19 in chronic kidney disease. J Intern Med 2021;290:166-78. [PMID: 33452733 DOI: 10.1111/joim.13239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
|
61 |
Sofi-Mahmudi A. Patients with COVID-19 may present some oral manifestations. Evid Based Dent 2021;22:80-1. [PMID: 34172917 DOI: 10.1038/s41432-021-0173-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
62 |
Lee AC, Li WT, Apostol L, Ma J, Taub PR, Chang EY, Rajasekaran M, Ongkeko WM. Cardiovascular, cerebrovascular, and renal co-morbidities in COVID-19 patients: A systematic-review and meta-analysis. Comput Struct Biotechnol J 2021;19:3755-64. [PMID: 34221254 DOI: 10.1016/j.csbj.2021.06.038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
63 |
Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. World J Radiol 2021; 13(6): 192-222 [PMID: 34249239 DOI: 10.4329/wjr.v13.i6.192] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
64 |
Sideris GA, Nikolakea M, Karanikola A, Konstantinopoulou S, Giannis D, Modahl L. Imaging in the COVID-19 era: Lessons learned during a pandemic. WJR 2021;13:193-223. [DOI: 10.4329/wjr.v13.i6.193] [Reference Citation Analysis]
|
65 |
Moskaleva EV, Petrova AG, Rychkova LV, Novikova EA, Vanyarkinа AS. Indicators of the Immune Status in Children after a New Coronavirus Infection. Acta biomedica scientifica 2021;6:58-62. [DOI: 10.29413/abs.2021-6.2.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
66 |
Novikova EA, Petrova AG, Moskaleva EV, Vanyarkinа AS, Rychkova LV. Retrospective of International Serological Studies on the Formation and Dynamics of the Humoral Immune Response to SARS-CoV-2: from 2020 to 2021. Acta biomedica scientifica 2021;6:47-57. [DOI: 10.29413/abs.2021-6.2.5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
67 |
Alonge AT, Ademusire BI, Epum CF, Adewale BA, Adefarati OS. Complications of Covid-19: A Systematic Review and Meta-Analysis. Journal of Microbiology and Infectious Diseases 2021;11:45-57. [DOI: 10.5799/jmid.951471] [Reference Citation Analysis]
|
68 |
Raina R, Mahajan ZA, Vasistha P, Chakraborty R, Mukunda K, Tibrewal A, Neyra JA. Incidence and Outcomes of Acute Kidney Injury in COVID-19: A Systematic Review. Blood Purif 2021;:1-14. [PMID: 34130296 DOI: 10.1159/000514940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
|
69 |
Ribeiro HS, Rodrigues AE, Cantuária J, Inda-Filho A, Bennett PN. Post-COVID-19 rehabilitation: a special look at chronic kidney disease patients. Ren Replace Ther 2021;7:33. [PMID: 34150334 DOI: 10.1186/s41100-021-00355-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
70 |
Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P, Rezaei-Tavirani M, Rahim F, Gilany K, Mohamadi-Jahani F, Adibi H, Larijani B. COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions. Front Cell Dev Biol 2021;9:675310. [PMID: 34195193 DOI: 10.3389/fcell.2021.675310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
71 |
Babajani A, Hosseini-Monfared P, Abbaspour S, Jamshidi E, Niknejad H. Targeted Mitochondrial Therapy With Over-Expressed MAVS Protein From Mesenchymal Stem Cells: A New Therapeutic Approach for COVID-19. Front Cell Dev Biol 2021;9:695362. [PMID: 34179022 DOI: 10.3389/fcell.2021.695362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
72 |
Bezerra R, Teles F, Mendonca PB, Damte T, Likaka A, Ferrer-Miranda E, Albuquerque JO, de Lima Filho JL. Outcomes of critically ill patients with acute kidney injury in COVID-19 infection: an observational study. Ren Fail 2021;43:911-8. [PMID: 34057014 DOI: 10.1080/0886022X.2021.1933530] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
73 |
Seidu S, Kunutsor SK, Cos X, Khunti K. Indirect impact of the COVID-19 pandemic on hospitalisations for cardiometabolic conditions and their management: A systematic review. Prim Care Diabetes 2021;15:653-81. [PMID: 34083122 DOI: 10.1016/j.pcd.2021.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
74 |
Pecly IMD, Azevedo RB, Muxfeldt ES, Botelho BG, Albuquerque GG, Diniz PHP, Silva R, Rodrigues CIS. A review of Covid-19 and acute kidney injury: from pathophysiology to clinical results. J Bras Nefrol 2021:S0101-28002021005048301. [PMID: 34057983 DOI: 10.1590/2175-8239-JBN-2020-0204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
75 |
Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ, Cruz-Martins N, El-Saber Batiha G. Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity. Eur J Pharmacol 2021;904:174196. [PMID: 34004207 DOI: 10.1016/j.ejphar.2021.174196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
|
76 |
Capaccione KM, Yang H, West E, Patel H, Ma H, Patel S, Fruauff A, Loeb G, Maddocks A, Borowski A, Lala S, Nguyen P, Lignelli A, D'souza B, Desperito E, Ruzal-Shapiro C, Salvatore MM. Pathophysiology and Imaging Findings of COVID-19 Infection: An Organ-system Based Review. Acad Radiol 2021;28:595-607. [PMID: 33583712 DOI: 10.1016/j.acra.2021.01.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
|
77 |
Daniella D, Kandarini Y, Mahadita GW. Risk Factors for Acute Kidney Injury in COVID-19 Patients: A Systematic Review. Open Access Maced J Med Sci 2021;9:118-123. [DOI: 10.3889/oamjms.2021.5846] [Reference Citation Analysis]
|
78 |
Pourfridoni M, Abbasnia SM, Shafaei F, Razaviyan J, Heidari-Soureshjani R. Fluid and Electrolyte Disturbances in COVID-19 and Their Complications. Biomed Res Int 2021;2021:6667047. [PMID: 33937408 DOI: 10.1155/2021/6667047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
|
79 |
Andargie TE, Tsuji N, Seifuddin F, Jang MK, Yuen PS, Kong H, Tunc I, Singh K, Charya A, Wilkins K, Nathan S, Cox A, Pirooznia M, Star RA, Agbor-Enoh S. Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury. JCI Insight 2021;6:147610. [PMID: 33651717 DOI: 10.1172/jci.insight.147610] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 19.0] [Reference Citation Analysis]
|
80 |
Fresán U, Guevara M, Trobajo-Sanmartín C, Burgui C, Ezpeleta C, Castilla J. Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study. J Clin Med 2021;10:1194. [PMID: 33809217 DOI: 10.3390/jcm10061194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
81 |
Barh D, Tiwari S, Andrade BS, Weener ME, Góes-Neto A, Azevedo V, Ghosh P, Blum K, Ganguly NK. A novel multi-omics-based highly accurate prediction of symptoms, comorbid conditions, and possible long-term complications of COVID-19. Mol Omics 2021;17:317-37. [PMID: 33683246 DOI: 10.1039/d0mo00189a] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
|
82 |
Xu C, Zhang T, Zhu N, Han M. Characteristics of COVID-19 patients with preexisting CKD history. Int Urol Nephrol 2021. [PMID: 33674950 DOI: 10.1007/s11255-021-02819-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
83 |
Kunutsor SK, Laukkanen JA. High fitness levels, frequent sauna bathing and risk of pneumonia in a cohort study: Are there potential implications for COVID-19? Eur J Clin Invest 2021;51:e13490. [PMID: 33426640 DOI: 10.1111/eci.13490] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
84 |
Bhasin B, Veitla V, Dawson AZ, Garacci Z, Sturgill D, Ozieh MN, Regner KR. AKI in Hospitalized Patients with COVID-19 and Seasonal Influenza: A Comparative Analysis. Kidney360 2021;2:619-28. [PMID: 35373047 DOI: 10.34067/KID.0007322020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
85 |
Sanchez-Russo L, Billah M, Chancay J, Hindi J, Cravedi P. COVID-19 and the Kidney: A Worrisome Scenario of Acute and Chronic Consequences. J Clin Med 2021;10:900. [PMID: 33668833 DOI: 10.3390/jcm10050900] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
86 |
Giani AM, Chen S. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Res 2021;53:102207. [PMID: 33677394 DOI: 10.1016/j.scr.2021.102207] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
87 |
Pothen L, Yildiz H, Samnick MM, Yombi JC. Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice? Clin Rheumatol 2021;40:1649-57. [PMID: 33452660 DOI: 10.1007/s10067-020-05572-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
88 |
Gu YY, Zhang M, Cen H, Wu YF, Lu Z, Lu F, Liu XS, Lan HY. Quercetin as a potential treatment for COVID-19-induced acute kidney injury: Based on network pharmacology and molecular docking study. PLoS One 2021;16:e0245209. [PMID: 33444408 DOI: 10.1371/journal.pone.0245209] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
|
89 |
Butt AA, Yan P. Rates and characteristics of SARS-CoV-2 infection in persons with hepatitis C virus infection. Liver Int 2021;41:76-80. [PMID: 33006798 DOI: 10.1111/liv.14681] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
|
90 |
Peña Rodríguez JC, Rogel Millán A, Ruiz Palacios P, Magallanes Mendoza M, Dávila Palomeque D, Hernández Vázquez L, Patiño Ortega R, Méndez Valdez C, Ramos Gordillo J. COVID-19 en pacientes en hemodiálisis crónica. Experiencia clínica y resultados en la Ciudad de México. Acta Médica Grupo Ángeles 2021;19:221-228. [DOI: 10.35366/100446] [Reference Citation Analysis]
|
91 |
Fung M, Otani I, Pham M, Babik J. Zoonotic coronavirus epidemics: Severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019. Ann Allergy Asthma Immunol 2021;126:321-37. [PMID: 33310180 DOI: 10.1016/j.anai.2020.11.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
|
92 |
Barh D, Tiwari S, Andrade BS, Weener ME, Góes-neto A, Azevedo V, Ghosh P, Ganguly NK. A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19.. [DOI: 10.1101/2020.12.08.20245753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
93 |
Wang P, Sha J, Meng M, Wang C, Yao Q, Zhang Z, Sun W, Wang X, Qie G, Bai X, Liu K, Chu Y. Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study. J Transl Med 2020;18:461. [PMID: 33287826 DOI: 10.1186/s12967-020-02655-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
|
94 |
Feldman EL, Savelieff MG, Hayek SS, Pennathur S, Kretzler M, Pop-Busui R. COVID-19 and Diabetes: A Collision and Collusion of Two Diseases. Diabetes 2020;69:2549-65. [PMID: 32938731 DOI: 10.2337/dbi20-0032] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 22.0] [Reference Citation Analysis]
|
95 |
Cui X, Gallini JW, Jasien CL, Mrug M. Autosomal Dominant Polycystic Kidney Disease does not significantly alter major COVID-19 outcomes among veterans.. [DOI: 10.1101/2020.11.25.20238675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
96 |
Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, Alinezhad F, Mohammadzadeh N, Hemmat N, Bannazadeh Baghi H. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg 2020;103:1783-96. [PMID: 32940201 DOI: 10.4269/ajtmh.20-0986] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 9.3] [Reference Citation Analysis]
|
97 |
Canatan D, Vives Corrons JL, De Sanctis V. The Multifacets of COVID-19 in Adult Patients: A Concise Clinical Review on Pulmonary and Extrapulmonary Manifestations for Healthcare Physicians. Acta Biomed 2020;91:e2020173. [PMID: 33525226 DOI: 10.23750/abm.v91i4.10665] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
98 |
Reid KRY, Queheillalt S, Martin T. Nursing's Response to the Executive Order to Advance American Kidney Health. Policy Polit Nurs Pract 2021;22:51-62. [PMID: 33081574 DOI: 10.1177/1527154420965932] [Reference Citation Analysis]
|
99 |
Alvarez-Belon L, Sarnowski A, Forni LG. COVID-19 infection and the kidney. Br J Hosp Med (Lond) 2020;81:1-8. [PMID: 33135911 DOI: 10.12968/hmed.2020.0574] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
100 |
Moreno-P O, Leon-Ramirez JM, Fuertes-Kenneally L, Perdiguero M, Andres M, Garcia-Navarro M, Ruiz-Torregrosa P, Boix V, Gil J, Merino E; COVID19-ALC Research Group. Hypokalemia as a sensitive biomarker of disease severity and the requirement for invasive mechanical ventilation requirement in COVID-19 pneumonia: A case series of 306 Mediterranean patients. Int J Infect Dis 2020;100:449-54. [PMID: 32950739 DOI: 10.1016/j.ijid.2020.09.033] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
|
101 |
Mann JK, Ndung'u T. The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19. Future Virology 2020;15:609-24. [DOI: 10.2217/fvl-2020-0170] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
102 |
Kunutsor SK, Laukkanen JA. Hepatic manifestations and complications of COVID-19: A systematic review and meta-analysis. J Infect 2020;81:e72-4. [PMID: 32579984 DOI: 10.1016/j.jinf.2020.06.043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
|
103 |
Diana NE, Kalla IS, Wearne N, Kariv S, Davidson B, Rusch J, Barday Z, Sheikh AM, Reiche S, Mohamed F, Saffer S, Dayal C, Venturas JP, Zamparini JM, van der Westhuizen D, Wasserman S, Papavarnavas N, Boloko L, de Wet T, Paget G, Mahomed A, Naidoo S, Jones ES, University of Witwatersrand, Johannesburg. Acute Kidney Injury during the COVID-19 Pandemic - Experience from Two Tertiary Centres in South Africa. WJCM 2020;2:137. [DOI: 10.18772/26180197.2020.v2n3a2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|